Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-04-01
2008-04-01
Woitach, Joseph (Department: 1633)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024100, C435S320100, C514S04400A
Reexamination Certificate
active
09884901
ABSTRACT:
In one aspect, the present invention provides nucleic acid expression cassettes that are predominantly expressed in the mammalian liver. The present invention also provides vectors comprising a nucleic acid expression cassette that is predominantly expressed in the mammalian liver. The present invention also provides methods of ameliorating the symptoms of a disease, the methods including the steps of introducing into the liver of a mammalian subject a vector comprising a nucleic acid expression cassette that encodes a polypeptide, and expressing a therapeutic amount of the polypeptide in the liver.
REFERENCES:
patent: 6610906 (2003-08-01), Kurachi et al.
patent: 6936243 (2005-08-01), Snyder et al.
patent: 2002/0076798 (2002-06-01), Miao et al.
patent: WO 95/11308 (1995-04-01), None
Simonet, W.S. et al., “Long-term Impaired Neutrophil Migration in Mice Overexpressing Human Interleukin-8”, 1994, J. Clin. Invest., vol. 94: pp. 1310-1319.
Kurachi, S. et al., “Role of Intron I in Expression of the Human Factor IX Gene”, 1995, J. Biol. Chem., vol. 270: pp. 5276-5281.
Jallat, S. et al., “Characterization of recombinant human Factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines”, 1990, EMBO Journal, vol. 9: pp. 3295-3301.
Nguyen, HQ et al., “Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epthelial growth and differentiation resulting in polycystic kidneys and other organ malformations”, 1996, Oncogene, vol. 12: pp. 2109-2119.
Fazio, S. et al. “Type III Hyperlipoproteinemic Phenotype in Transgenic Mice Expressing Dysfunctional Apolipoprotein E”, 1993, J. Clin. Invest., vol. 92: pp. 1497-1503.
Miao, C.H., et al., “A Nonviral Approach: Long-Term and Therapeutic Level Human Factor IX Gene Expression Due to Retention of Optimal HFIX Plasmids in Hepatocytes After Naked DNA Transfer,”Blood 96(11, 1):210 (Abstract), Nov. 2000.
Miao, C.H., et al., “Inclusion of the Hepatic Locus Control Region, an Intron, and Untranslated Region Increases and Stabilizes Hepatic Factor IX Gene Expression In Vivo but not In Vitro,”Molecular Therapy 1(6):522-532, Jun. 2000.
Long G.L. et al.,Biochemistry, 23:4828-37 (1984).
Armentano, D. et al.,Proc. Natl. Acad. Sci.USA, 87:6141-5 (1990).
Le, M. et al.,Blood, 89:1254-9 (1997).
Hafenrichter, D.G. et al.,Blood, 84:3394-404 (1994).
Kaleko, M. et al.,J. Cell. Biochemistry, 21(A):366 (1995).
Shachter, N.S. et al.,J. Lipid Res., 34:1699-707 (1993).
Okuyama, T. et al.,Hum. Gene Ther., 7:637-45 (1996).
Simonet, W.S. et al.,J. Biol. Chem., 268:8221-9 (1992).
Dang, Q. et al.,J. Biol. Chem., 270:22577-85 (1995).
Budker, V. et al.,Gene Ther., 3:593-8 (1996).
Liu, F. et al.,Gene Ther., 6:1258-1266 (1999).
Zhang, G. et al.,Human Gene Ther., 10:1735-1737 (1999).
Brinster et al., “Introns increase transcriptional efficiency in transgenic mice”.PNAsU.S.A, 85(3):836-40 (1988).
Clayton et al., “Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes”,Mol Cell Biol., 3(9):1552-1561 (1983).
Isom et al., “Persistence of liver-specific messenger RNA in cultured hepatocytes: different regulatory events for different genes”,J Cell Biol., 105(6 Pt2):2877-85 (1987).
Kay et al., “Direct Hepatic Gene Delivery in Mice results in Persistant Expression of Human Alpha-1-Antitrypsin in vivo”,Human Gene Therapy, 3:641-647 (1992).
Kay et al., “Expression of human alpha-1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes”,PNAsU.S.A., 89:89-93 (1992).
Kay, M.A. et al., “Therapeutic Serum Concentrations of Human Alpha 1-Antitrypsin after Adrenoviral-Mediated Gene Transfer into Mouse Hepatocytes”,Hepatology, 21:515-519 (1995).
Palmiter et al., “Heterologous introns can enhance expression of transgenes in mice”,PNAsU S A, 88(2):478-82 (1991).
Kay Mark A.
Miao Carol H.
Burkhart Michael
Perkins Coie LLP
The Board of Trustees of the Leland Stanford Junior University
University of Washington
Woitach Joseph
LandOfFree
Liver-specific gene expression cassettes, and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Liver-specific gene expression cassettes, and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liver-specific gene expression cassettes, and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3917560